Leucht Stefan, Heres Stephan
Klinik und Poliklinik für Psychiatrie und Psychotherapie, Klinikum rechts der Isarder, Technischen Universität München, Ismaningerstrasse 22, 81675 Munich, Germany.
J Clin Psychiatry. 2006;67 Suppl 5:3-8.
Partial adherence and nonadherence to medication continue to be problems in the treatment of patients with schizophrenia. Nonadherence to medication has a negative impact on the course of illness for these patients as is shown by data on relapse, rehospitalization, time to remission, and attempted suicide. Several factors that contribute to poor adherence have been identified and need to be taken into account when attempting to address the problem of nonadherence. These risk factors relate to the patient, his or her illness and social situation, and the physician. Among the measures that have the potential to improve adherence to medication are psychosocial interventions, psychoeducation in the form of professional, peer-to-peer or family-to-family interventions, and shared decision making.
在精神分裂症患者的治疗中,部分依从和不依从药物治疗仍然是问题。如关于复发、再次住院、缓解时间和自杀未遂的数据所示,不依从药物治疗对这些患者的病程有负面影响。已经确定了几个导致依从性差的因素,在试图解决不依从问题时需要加以考虑。这些风险因素与患者、其疾病和社会状况以及医生有关。有可能提高药物依从性的措施包括心理社会干预、以专业人员、同伴或家庭对家庭干预形式进行的心理教育以及共同决策。